| Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2008: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Research Abstract |
Metabolic syndrome with local inflammation progresses to atherosclerosis and non-alcoholic fatty liver disease (NAFLD). The present study examined the possible involvement of group IVA phospholipase A_2 (IVA-PLA_2), which catalyzes the first step of the biosynthesis of inflammatory lipid mediators, in the development of (1) atherosclerosis and (2) NAFLD using IVA-PLA_2-knockout (KO) mice.
(1) Wild-type mice on high-fat diets developed the formation of atherosclerotic lesions in the aortic root with low serum levels of HDL-cholesterol (HDL-C), compared with wild-type mice fed normal diets. IVA-PLA_2-KO mice on high-fat diets exhibited resistance to the formation of lesions even with low serum levels of HDL-C. These findings indicate that a deficiency of IVA-PLA_2 alleviates the high-fat diet-induced formation of atherosclerotic lesions without improving dyslipidemia.
(2) Wild-type mice on high-fat diets developed fatty liver, compared with wild-type mice fed normal diets. However, these high-fat diet-induced alterations were markedly decreased in IVA-PLA_2-KO mice. Furthermore, high-fat diets induced liver fibrosis with the expression of collagen type I A_2 and transforming growth factor-β mRNA in the liver of wild-type mice but not IVA-PLA_2-KO mice. These findings indicate that a deficiency of IVA-PLA_2 protected mice against the high-fat diet-induced development of NAFLD with fibrosis.
The present results suggest the possible involvement of IVA-PLA_2 in development of atherosclerosis and NAFLD.
|
